In Medical Reporting, the Impact of Patients ’ Stories

A highly unusual response to my article on insurance obstacles to obtaining powerful new cholesterol-lowering drugs came from the very top: the leaders of one of the two companies making the drugs.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Cholesterol Drugs (Pharmaceuticals) Health Insurance and Managed Care Praluent (Drug) Regeneron Pharmaceuticals Inc Sanofi SA Repatha (Drug) Amgen Inc Source Type: news